Anti-angiogenic therapy for lung cancer
Data(s) |
01/01/2010
|
---|---|
Resumo |
This is the protocol for a review and there is no abstract. The objectives are as follows:<br /><br />To determine the benefits and harms of angiogenesis inhibitors in the treatment of lung cancer when given alone, following or in combination with chemotherapy or chemo-radiotherapy (in the case of locally advanced non-metastatic NSCLC or limited stage SCLC). |
Identificador | |
Idioma(s) |
eng |
Publicador |
John Wiley & Sons |
Relação |
http://dro.deakin.edu.au/eserv/DU:30046496/khasraw-antiangiogenictherapy-2010.pdf http://dx.doi.org/10.1002/14651858.CD008047 |
Direitos |
2010, The Cochrane Collaboration |
Palavras-Chave | #angiogenesis #lung cancer #treatment |
Tipo |
Journal Article |